Veronica Ajewole to Female
This is a "connection" page, showing publications Veronica Ajewole has written about Female.
Connection Strength
0.097
-
Ajewole VB, Cox JE, Swan JT, Chikermane SG, Lamoth B, Iso T, Okolo LO, Ford CL, Schneider AM, Hobaugh EC, Baker KR. Incidence of chemotherapy-induced peripheral neuropathy within 12?weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study. Support Care Cancer. 2020 Apr; 28(4):1901-1912.
Score: 0.046
-
Egbejimi A, Ajewole V, Dongarwar D, Kaur M, Phillips M, Liang J, Fadel M, Lota L, Simon J, Otule M, Taylor K, Oguibe G, Salihu HM, Olaleye O. Racial Disparities in Preterm Birth among Pregnant Women with Obesity. South Med J. 2023 06; 116(6):471-477.
Score: 0.015
-
Thompson J, Onyenaka C, Oduguwa E, Dongarwar D, Gendra S, Coker V, Kutse S, Blanco M, Nwangwu O, King C, Enamorado E, Bakare O, Ajewole VB, Spooner KK, Salemi JL, Aliyu MH, Salihu HM, Olaleye OA. Trends and Racial/Ethnic Disparities in the Rates of Pre-eclampsia by HIV Status in the US. J Racial Ethn Health Disparities. 2021 06; 8(3):670-677.
Score: 0.012
-
Dongarwar D, Taylor J, Ajewole V, Anene N, Omoyele O, Ogba C, Oluwatoba A, Giger D, Thuy A, Argueta E, Naik E, Salemi JL, Spooner K, Olaleye O, Salihu HM. Trends in Appendicitis Among Pregnant Women, the Risk for Cardiac Arrest, and Maternal-Fetal Mortality. World J Surg. 2020 Dec; 44(12):3999-4005.
Score: 0.012
-
Solomon JM, Ajewole VB, Schneider AM, Sharma M, Bernicker EH. Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer center. J Oncol Pharm Pract. 2019 Oct; 25(7):1564-1569.
Score: 0.011